Photo of Amol Akhade from hiranandanihospital.org
Sep 26, 2024, 16:51
Amol Akhade: Tropion Breast 01 trial in Hr positive and Her2 low advanced MBC
Amol Akhade shared a post on Linkedin:
”Surprised?
I am .
No OS inspite of good PFS curves for Datopotamab Deruxtecan in Tropion Breast 01 trial in Hr positive and Her2 low advanced MBC in later Line . Not All ADC are Same.”
Source: Amol Akhade/X
Dr. Amol Akhade is a senior consultant medical oncologist and hemato-oncologist. He has received his super specialization training in hemato-oncology and medical oncology from Tata Memorial Hospital. He specialises in chemotherapy for hematological cancers as well as solid tumors. He also specialises in allogenic and autologous bone marrow transplant. Currently, he is a Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 1, 2025, 17:02
Mar 1, 2025, 16:29
Mar 1, 2025, 15:32
Mar 1, 2025, 15:20
Mar 1, 2025, 15:12
Mar 1, 2025, 14:44
Mar 1, 2025, 14:24